Group One Trading’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,100
| Closed | -$139K | – | 8536 |
|
|
2025
Q4 | $139K | Sell |
4,100
-7,700
| -65% | -$239K | ﹤0.01% | 4704 |
|
|
2025
Q3 | $304K | Sell |
11,800
-8,000
| -40% | -$105K | ﹤0.01% | 4206 |
|
|
2025
Q2 | $158K | Buy |
19,800
+18,800
| +1,880% | +$143K | ﹤0.01% | 4564 |
|
|
2025
Q1 | $9.76K | Sell |
1,000
-6,563
| -87% | -$64.5K | ﹤0.01% | 6281 |
|
|
2024
Q4 | $95.6K | Buy |
7,563
+3,638
| +93% | +$46.2K | ﹤0.01% | 4558 |
|
|
2024
Q3 | $63.1K | Sell |
3,925
-9,625
| -71% | -$195K | ﹤0.01% | 4491 |
|
|
2024
Q2 | $331K | Sell |
13,550
-15,675
| -54% | -$724K | ﹤0.01% | 2944 |
|
|
2024
Q1 | $2.1M | Buy |
29,225
+7,912
| +37% | +$1.1M | 0.01% | 1445 |
|
|
2023
Q4 | $4.24M | Buy |
21,313
+1,025
| +5% | +$127K | 0.01% | 1260 |
|
|
2023
Q3 | $2.7M | Sell |
20,288
-912
| -4% | -$149K | 0.01% | 1393 |
|
|
2023
Q2 | $3.17M | Buy |
21,200
+3,175
| +18% | +$495K | 0.01% | 1319 |
|
|
2023
Q1 | $2.65M | Sell |
18,025
-1,913
| -10% | -$387K | 0.01% | 1305 |
|
|
2022
Q4 | $3.16M | Buy |
19,938
+263
| +1% | +$42.1K | 0.01% | 1454 |
|
|
2022
Q3 | $3.79M | Buy |
19,675
+4,637
| +31% | +$877K | 0.01% | 1387 |
|
|
2022
Q2 | $2.19M | Buy |
15,038
+15,025
| +115,577% | +$2M | ﹤0.01% | 1976 |
|
|
2022
Q1 | $2K | Sell |
13
-512
| -98% | -$96.7K | ﹤0.01% | 7744 |
|
|
2021
Q4 | $154K | Sell |
525
-1,025
| -66% | -$274K | ﹤0.01% | 5352 |
|
|
2021
Q3 | $385K | Sell |
1,550
-4,388
| -74% | -$1.16M | ﹤0.01% | 4483 |
|
|
2021
Q2 | $1.51M | Buy |
5,938
+1,225
| +26% | +$229K | ﹤0.01% | 2943 |
|
|
2021
Q1 | $837K | Buy |
4,713
+4,400
| +1,406% | +$725K | ﹤0.01% | 3432 |
|
|
2020
Q4 | $49K | Buy |
+313
| New | +$68.1K | ﹤0.01% | 5022 |
|
Group One Trading's RAPT Position: Q1 2026 in Review
Group One Trading sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 5,282 shares — an estimated $179K sold.
Group One Trading first reported a position in RAPT in Q4 2020 and held it in 7 quarters. The position peaked at $179K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Group One Trading reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 5,282 RAPT Therapeutics shares in Q1 2026, an estimated $179K.
- Group One Trading first reported a position in RAPT Therapeutics in Q4 2020 and held it in 7 quarters.
- Group One Trading's RAPT Therapeutics position peaked at $179K in Q4 2025.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.